Liver fibrosis scores and prognosis in patients with cardiovascular diseases: A systematic review and meta‐analysis

医学 内科学 非酒精性脂肪肝 纤维化 胃肠病学 荟萃分析 队列 队列研究 肝病 危险系数 疾病 脂肪肝 置信区间
作者
Zhiwei Yan,Yang Liu,Wei Li,Xiaopeng Zhao,Weichun Lin,Jing Zhang,Shuchun Yu,Jianyong Ma,Jingfeng Wang,Peng Yu,Weiguang Li,Xiao Liu
出处
期刊:European Journal of Clinical Investigation [Wiley]
卷期号:52 (11) 被引量:21
标识
DOI:10.1111/eci.13855
摘要

In patients with nonalcoholic fatty liver disease, liver fibrosis was associated with a higher risk of cardiovascular events. However, the relationship between liver fibrosis scores and clinical outcomes in patients with cardiovascular disease remains unclear.Searching from PubMed, EMBASE and Cochrane Library databases yielded cohort studies that reported adjusted effect size between liver fibrosis scores (Fibrosis-4 score [FIB-4] or NAFLD fibrosis score [NFS]) and prognosis in patients with cardiovascular disease. The effect size was computed using a random-effects model.This meta-analysis included twelve cohort studies involving 25,252 patients with cardiovascular disease. Participants with the highest baseline level of FIB-4 or NFS had a significantly increased risk of cardiovascular events (FIB-4, HR: 1.75, 95% CI: 1.53-2.00, I 2 = 0%; NFS, HR: 1.92, 95% CI: 1.50-2.47, I 2 = 47%). This finding was consistent with the analysis of FIB-4 or NFS as a continuous variable (per 1-unit increment FIB-4, HR: 1.15, 95% CI: 1.06-1.24, I 2 = 72%; NFS, HR: 1.15, 95% CI: 1.07-1.24, I 2 = 71%). Furthermore, participants with the highest levels of FIB-4 or NFS had a greater risk of cardiovascular mortality (FIB-4, HR: 2.07, 95% CI: 1.19-3.61, I 2 = 89%; NFS, HR: 3.72, 95% CI: 2.62-5.29, I 2 = 60%) and all-cause mortality (FIB-4, HR: 1.81, 95% CI: 1.24-2.66, I 2 = 90%; NFS, HR: 3.49, 95% CI: 2.82-4.31, I 2 = 25%). This result was also consistent as a continuous variable.Higher levels of FIB-4 and NFS are related to an increased risk of cardiovascular events, cardiovascular mortality and all-cause mortality in patients with cardiovascular disease.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yuanyuan发布了新的文献求助30
1秒前
量子星尘发布了新的文献求助100
1秒前
谨慎的幻悲完成签到,获得积分10
1秒前
阿连发布了新的文献求助10
1秒前
Steven发布了新的文献求助10
2秒前
3秒前
5秒前
5秒前
xww关闭了xww文献求助
6秒前
六两芫荽完成签到,获得积分10
6秒前
6秒前
7秒前
8秒前
9秒前
XLL发布了新的文献求助10
10秒前
1ssd发布了新的文献求助10
10秒前
yuanyuan完成签到,获得积分10
10秒前
庾摇伽完成签到 ,获得积分10
11秒前
哈哈关注了科研通微信公众号
11秒前
12秒前
5High_0发布了新的文献求助10
12秒前
Phee发布了新的文献求助10
13秒前
ZGAAQj发布了新的文献求助10
13秒前
eghiefefe完成签到,获得积分10
14秒前
Snoopy发布了新的文献求助10
14秒前
14秒前
研友_8K2QJZ完成签到,获得积分10
15秒前
rangersl1关注了科研通微信公众号
15秒前
Robert完成签到,获得积分10
15秒前
Orange应助欣慰的乌冬面采纳,获得10
15秒前
16秒前
Ava应助xu采纳,获得10
19秒前
xr完成签到 ,获得积分10
20秒前
20秒前
共享精神应助琪凯定理采纳,获得10
20秒前
贝贝完成签到 ,获得积分10
20秒前
箐筝完成签到,获得积分10
21秒前
Chengcheng发布了新的文献求助10
21秒前
Bio应助aike采纳,获得50
22秒前
22秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Effective Learning and Mental Wellbeing 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975900
求助须知:如何正确求助?哪些是违规求助? 3520207
关于积分的说明 11201602
捐赠科研通 3256663
什么是DOI,文献DOI怎么找? 1798403
邀请新用户注册赠送积分活动 877564
科研通“疑难数据库(出版商)”最低求助积分说明 806430